Open Access

Microglial dynamics after axotomy-induced retinal ganglion cell death

Journal of Neuroinflammation201714:218

https://doi.org/10.1186/s12974-017-0982-7

Received: 31 July 2017

Accepted: 16 October 2017

Published: 9 November 2017

Abstract

Background

Microglial cells (MCs) are the sentries of the central nervous system. In health, they are known as surveying MCs because they examine the tissue to maintain the homeostasis. In disease, they activate and, among other functions, become phagocytic to clean the cellular debris. In this work, we have studied the behavior of rat retinal MCs in two models of unilateral complete intraorbital optic nerve axotomy which elicit a different time course of retinal ganglion cell (RGC) loss.

Methods

Albino Sprague-Dawley rats were divided into these groups: (a) intact (no surgery), (b) fluorogold (FG) tracing from the superior colliculi, and (c) FG tracing + crush or transection of the left optic nerve. The retinas were dissected from 2 days to 2 months after the lesions (n = 4–12 group/lesion and time point) and then were subjected to Brn3a and Iba1 double immunodetection. In each intact retina, the total number of Brn3a+RGCs and Iba+MCs was quantified. In each traced retina (b and c groups), FG-traced RGCs and phagocytic microglial cells (PMCs, FG+Iba+) were also quantified. Topographical distribution was assessed by neighbor maps.

Results

In intact retinas, surveying MCs are homogenously distributed in the ganglion cell layer and the inner plexiform layer. Independently of the axotomy model, RGC death occurs in two phases, one quick and one protracted, and there is a lineal and topographical correlation between the appearance of PMCs and the loss of traced RGCs. Furthermore, the clearance of FG+RGCs by PMCs occurs 3 days after the actual loss of Brn3a expression that marks RGC death. In addition, almost 50% of MCs from the inner plexiform layer migrate to the ganglion cell layer during the quick phase of RGC loss, returning to the inner plexiform layer during the slow degeneration phase. Finally, in contrast to what happens in mice, in rats, there is no microglial phagocytosis in the contralateral uninjured retina.

Conclusions

Axotomy-induced RGC death occurs earlier than RGC clearance and there is an inverse correlation between RGC loss and PMC appearance, both numerically and topographically, suggesting that phagocytosis occurs as a direct response to RGC death rather than to axonal damage.

Keywords

PhagocyteIba1Brn3aTranscellular labelingMigrationFluorogold

Background

In rodents, retinal ganglion cell (RGC) loss after optic nerve axotomy is a well-documented process that occurs in two phases [1]. The first one is quick and devastating, lasts around 14 days, and causes the loss of ~ 85% of RGCs. Then, RGC death takes a slower but steady pace in such a way that 15 months after the injury, around 1% of the original population remains [2]. Furthermore, in rats, the rate of RGC loss is modulated by the distance from the optic nerve head at which the axotomy is performed, slower with longer distances [2, 3].

After axotomy, damaged RGCs die by apoptosis [4, 5]. Apoptotic cells initiate a highly controlled cascade of events that finishes when the cell bodies are cleared from the tissue by phagocytes [6, 7] which, in the central nervous system, are the microglial cells (MCs).

In the healthy retina, MCs are located on four layers: the retinal nerve fiber layer (RNFL) that contains RGC axons; the ganglion cell layer (GCL), where RGC somatas and displaced amacrine cells lie; the inner plexiform layer (IPL); and the outer plexiform layer (OPL). While plexiform layers are mainly formed by neuropil, the IPL also contains displaced RGCs (dRGCs) [8].

MC surveys the tissue (surveying MCs (SMCs)), keep the homeostasis, and stabilize the synapses [9, 10]. Upon neuronal death, MCs activate [11, 12] and migrate to the damaged region [13] to participate in the careful clearance of cellular debris and to repair the local damage (reviewed in [1416]). This removal is critical to maintain tissue integrity (reviewed in [17]).

The phagocytic uptake of MCs can be measured in vitro by different assays such as administration of fluorescent bioparticles or cell debris previously labeled [18]. In vivo, phagocytic microglial cells (PMCs) can be identified by transcellular labeling, a process that occurs when a MC engulfs a dying fluorescent neuron [1924]. This is a powerful approach to study PMC behavior and tissue clearing, provided that a given neuronal population is first labeled and then injured.

In rats and mice, almost the whole population of RGCs (~ 98% [25, 26]) can be traced from both superior colliculi with fluorogold (FG), a fluorescent retrograde tracer. Thus, if after RGC tracing the optic nerve is injured, it is possible to asses at the same time RGC clearance and the appearance of transcellularly labeled MCs [2124]. Using this tool in mice, we have shown that after unilateral axotomy, the appearance of PMCs and the clearance of traced RGCs in the injured retina are linearly correlated [21, 24]. Interestingly, in the contralateral uninjured retina of pigmented mice, some MCs become phagocytic and their number and distribution are constant and independent of RGC survival in the injured retina.

There are many works describing the microglial response to injury, activation mechanisms and phenotypes, and release of inflammatory mediators or their involvement in neurodegeneration and neuroprotection [2733]. But little is known of their numerical and topographical dynamics and their correlation with the dying neurons, for instance, is the temporal and topographical course of PMC appearance regulated by the course of neuronal death? Is neuronal clearance the same as neuronal death? Is there a contralateral retinal response involving PMC appearance in adult rats? Do MCs travel from the outer retinal layers to the inner retina to cope with the massive RGC death triggered by axotomy?

To answer these questions, we have used RGC tracing and immunodetection of microglial cells (Iba1) and viable RGCs (Brn3a) in the same retinas after two different axotomy models.

Methods

Animal handling

Adult female albino Sprague-Dawley rats (200 g, n = 80) were obtained from the University of Murcia breeding colony. All animals were treated in compliance with the European Union guidelines for Animal Care and Use for Scientific Purpose (Directive 2010/63/EU) and the guidelines from the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research. All procedures were approved by the Ethical and Animal Studies Committee of the University of Murcia, Spain (REGA 300305440012).

Animals undergoing surgery were anesthetized by intraperitoneal injection of a mixture of ketamine (60 mg/kg; Ketolar, Pfizer, Alcobendas, Madrid, Spain) and xylazine (10 mg/kg; Rompum, Bayer, Kiel, Germany). Analgesia was provided by subcutaneous administration of buprenorphine (0.1 mg/kg; Buprex, buprenorphine 0.3 mg/mL; Schering-Plough, Madrid, Spain). During and after surgery, the eyes were covered with an ointment (Tobrex; Alcon, S. A., Barcelona, Spain) to prevent corneal desiccation.

The animal groups are the following: (i) intact, no surgery; (ii) tracing controls, tracing from the superior colliculi (SCi), analyzed 7 days or 2 months later (9 weeks); (iii) axotomized, tracing from the SCi, and 1 week later optic nerve crush (ONC) or optic nerve transection (ONT), retinal analysis 2, 5, 9, 14 days or 2 months (9 weeks tracing) later. Injured retinas are the left ones, and contralateral retinas the right ones.

Retrograde tracing

After the exposure of both SCi, a pledge of gelatin sponge soaked in 3% fluorogold (FG, Fluorochrome, LLC, USA) dissolved in 10% dimethyl sulfoxide/saline was applied onto both SCi 7 days prior optic nerve injury, or 7 days or 9 weeks before sacrifice (traced but otherwise intact retinas), following standard techniques in our laboratory [8, 23, 24, 34, 35].

Optic nerve injuries

Seven days after RGC tracing and according to previous studies, the left optic nerve was crushed or transected at 3 or 0.5 mm from the optic disc, respectively [2, 4, 3436]. With these settings, ONC elicits a slower RGC death than ONT [2, 34].

Tissue preparation and sectioning

Unless otherwise stated, all reagents were from Sigma-Aldrich Quimica S.A. Madrid, Spain.

Animals were sacrificed with an intraperitoneal injection of an overdose of sodium pentobarbital (Dolethal, Vetoquinol; Especialidades Veterinarias, S.A., Alcobendas, Madrid, Spain). All animals were perfused transcardially with 0.9% saline solution followed by 4% paraformaldehyde in 0.1 M phosphate buffer.

The retinas (n = 4–12/group and time point, see tables) were dissected as flattened whole mounts as previously described [34]. Some eye cups (n = 3/group and time point) were cryoprotected in a series of sucrose gradients, embedded in optimal cutting temperature medium (OCT, Tissue-Tek, Sakura-Finetek, VWR, Barcelona, Spain), frozen, and sectioned in a cryostat at 14-μm thickness.

Immunohistofluorescence

Double immunodetection of RGCs and MCs was carried out as previously described [2, 11, 21, 35, 37]. Healthy RGCs were detected using goat α-Brn3a (C-20; Santa-Cruz Biotechnology, Heidelberg, Germany) diluted 1:750 and microglial cells using rabbit α-Iba1 antibody (ionized calcium-binding adapter molecule 1; Wako Chemicals GmbH, Neuss, Germany) diluted 1:1000. Secondary detection was carried out with donkey α-goat and donkey α-rabbit (Alexa Fluor 594 and 488 respectively; Molecular Probes; Thermo Fisher Scientific, Madrid, Spain) diluted at 1:500. In some retinal sections, all nuclei were counterstained using antifading mounting media with DAPI (4′,6-diamidino-2-phenylindole, Vectashield mounting medium with DAPI; Vector Laboratories, Palex Medical, Barcelona, Spain).

Image acquisition

Whole-mounted retinas where photographed focusing firstly on the GCL and secondly on the IPL. All images were acquired using an epifluorescence microscope (Axioscop 2 Plus; Zeiss Mikroskopie, Jena, Germany) equipped with a computer-driven motorized stage (ProScan H128 Series; Prior Scientific Instruments, Cambridge, UK) controlled by image analysis software (Image-Pro Plus, IPP 5.1 for Windows; Media Cybernetics, Silver Spring, MD). Retinal photomontages were reconstructed from 154 (11 × 14) individual images by zigzag tiling, as reported [2, 25, 38].

Quantification

FG+RGCs in intact and contralateral to the lesion retinas, and Brn3a+RGCs in all retinas, were automatically quantified using our previously described methods [25, 34]. After injury, microglial cells became transcellularly labeled (PMCs: FG+Iba1+), being for the automated routine impossible to tell them apart from traced RGCs Thus, FG+RGCs were manually quantified (FG+Iba1) and their total number estimated using previously reported methods [11]. Briefly, the retinas were divided into three concentric rings (central, equatorial, and peripheral) and four samples within each were selected (0.25 mm2/sample). Each sample corresponded to a retinal quadrant, therefore, three samples per quadrant and four samples per ring. The area of each ring was measured, and the total number of FG+RGCs in a given ring were estimated from the mean number quantified in its four samples, thus giving back the number of FG+RGCs in the central, medial, and peripheral retina. The total number of FG+RGCs per retina was the sum of the partial values. This method was validated in intact retinas, where FG+RGCs were quantified automatically and manually (for more details, see [11]).

All non-phagocytic MCs (Iba1+FG) and PMCs (Iba1+FG+) were manually dotted on the retinal photomontages using Adobe Photoshop CS 8.0.1; (Adobe Systems, Inc., San Jose, CA), and the dots were automatically quantified (IPP software) [2, 8, 24, 39]. Quantitative data from all populations were exported to a spreadsheet application (Microsoft Office Excel 2003; Microsoft Corporation, Redmond, WA) for further analyses.

Spatial distribution

The spatial distribution of RGCs and MCs was assessed by the near neighbor algorithm as reported [2, 21, 24, 39, 40]. The position of each Brn3a+RGC or dot (microglial cell) in the photomontage was translated to an X,Y location using as reference the optic nerve (0,0 point). Maps were plotted using SigmaPlot (SigmaPlot 9.0 for Windows; Systat Software, Inc., Richmond, CA, USA). In addition, using a color code, these maps depict the number of neighbors around a given cell in a given radius (see Fig. 1 legend).
Fig. 1

Microglial cells are homogeneously distributed in intact retinas. a Cross section showing the location of Iba1+MCs (green) and Brn3a+RGCs (red) in intact retinas. Note that some MCs in the IPL are lying on top of the INL. b Magnification from an intact flat-mounted retina focused on the RNFL/GCL showing Iba1+MCs and Brn3a+RGCs. b’ Iba1+MCs and displaced Brn3a+RGCs in the same area as b but changing the focus to the IPL/INL. c Neighbor map of an intact retina showing the distribution of MCs in the GCL. c’ Neighbor map from the same retina showing the distribution of MCs in the IPL. d Magnification from a control retina 7 days after fluorogold tracing (white), immunodetected with Brn3a (red). In these retinas, no PMCs were observed. In control retinas analyzed 2 months after tracing (e, f) some PMCs (yellow arrows) were observed in the GCL (e, f left) and IPL (f right). g Neighbor map of an intact retina showing the distribution of Brn3a+RGCs. h Retinal outline showing the position of the few PMCs found in control retinas analyzed 2 months after tracing. i, j Retinal outlines showing the location of the PMCs found in contralateral to the lesion retinas analyzed 2 months after the unilateral ONC (i) or ONT (j). i’, j’ Brn3a+RGCs neighbor maps from the same retinas as in i, j. For this and the subsequent figures: The number of cells represented is shown below each map. Neighbor maps represent the number of neighbors around each cell (dot) within a given radius and color scale. For MC representation, the radius is 0.276 mm and the scale (c, bottom) goes from 0 to 24 (purple) to ≥ 250–274 neighbors (bright green). For RGCs, the radius is 0.0552 mm and the color scale (g, bottom) goes from 0 to 4 (purple) to ≥ 35–39 (dark red) neighbors. D dorsal, V ventral, T temporal, N nasal, RR right retina, RNFL retinal nerve fiber layer, GCL ganglion cell layer, IPL inner plexiform layer, INL inner nuclear layer, OPL outer plexiform layer, ONL outer nuclear layer, ONC optic nerve crush, ONT optic nerve transection, MC microglial cell, PMC phagocytic microglial cell, m months, d days

Statistical analysis

Data were analyzed with GraphPad Prism v.7 (GraphPad San Diego, USA). Each cell type was analyzed independently along time within each lesion and between lesions (one-way ANOVA, post hoc Tukey’s test). Differences were considered significant when p < 0.05. Data are presented as mean ± standard deviation. Correlation analyses (microglial cells vs. RGCs, or cells vs. time) were modeled using the same program and were considered significant when R 2 (goodness of the fit) was ≥ 0.9.

Results

In all the retinas except the intact ones, RGCs were identified by Brn3a immunodetection and tracing. The loss of Brn3a signal announces that a RGC is dead [2, 4]. A traced RGC might not be viable (no Brn3a expression), but it may still be detectable because the FG filling the RGC soma is an exogenous compound that will disappear from the tissue only upon microglial clearance. In intact retinas, MCs are called surveying MCs (Iba1+). In the experimental retinas, we counted Iba1+FG+ PMCs, and Iba1+FG MCs that may or may not have been activated, for accuracy, and we termed them non-phagocytic microglial cells (non-PMCs).

We could not discriminate between the RNFL and GCL. Also, we acquired images from the IPL and the inner limit of the inner nuclear layer (INL) because we used the dRGCs as pegs. For simplicity, we will refer to these layers in the text as GCL or IPL, respectively.

Intact retinas

As observed in the retinal section in Fig. 1a, SMCs are found in the GCL, IPL, and OPL. In the IPL, some MCs lie on the inner limit of the INL. Using flat mounts, we quantified their total number in the GCL or IPL (Fig. 1b, b’), which contain, respectively, RGC axons and somata, or their dendrites and dRGCs.

The total number of SMCs in the GCL and IPL is very similar (Table 1), although slightly higher in the GCL. The ratio RGC/MC is 6:1 if we take into account only MCs in the GCL, but if we add the MCs in the IPL, that is MCs in the GC complex, this ratio becomes 3:1. In both layers, SMCs are homogenously distributed (Fig. 1c, c’, Table 1).
Table 1

Intact, tracing control, and contralateral to the injury retinas

  

Intact (n = 4)

Tracing control

Contralateral (n = 80/72*)

7 days (n = 8)

2 months (n = 4)

RNFL/GCL

Brn3a+RGCs

82,530 ± 766

81,504 ± 798

81,368 ± 491

81,486 ± 2272

FG+RGCs

 

81,829 ± 1246

58,948§ ± 3381

81,513 ± 1425

RNFL/GCL

SMCs

14,151 ± 1186

   

PMCs

 

0 ± 0

6 ± 2

1 ± 3

IPL/INL

SMCs

11,006 ± 989

   

PMCs

 

0 ± 0

1 ± 1

 

GCC

SMCs

25,156 ± 1367

0 ± 0

  

PMCs

 

0 ± 0

7 ± 3

 

Mean number ± standard deviation of Brn3a+RGCs, FG+RGCs, surveying microglial cells (SMCs), and phagocytic microglial cells (PMCs) counted in the same retinas within each group. PMCs were quantified in the retinas that had been traced with fluorogold 7 days or 2 months before sacrifice to match the tracing standard (7 days) and the longer tracing times used in the injured retinas (see Table 2)

FG fluorogold, RGCs retinal ganglion cells, RNFL/GCL retinal nerve fiber layer/ganglion cell layer, IPL/INL inner plexiform layer + inner limit inner nuclear layer, GCC ganglion cell complex (RFNL/GCL + IPL/INL)

§The number of FG+RGCs 2 months after tracing is significantly smaller than at 7 days because FG is not a permanent dye [39, 41, 42], while the number of Brn3a+RGCs remains unaltered. In 2-month traced retinas, there are some PMCs, although this is not significant compared to 7 days of tracing or intact retinas (one-way ANOVA, Tukey’s post hoc test, p > 0.05)

*The number of contralateral retinas amounts to 80 for Brn3a+RGCs and PMCs (see Table 2) and to 72 for FG+RGCs (2-month time point excluded). No significant differences were observed between contralateral and control or intact retinas (one-way ANOVA test, Tukey’s post hoc test, p > 0.05)

Tracing controls and contralateral retinas

In traced retinas, FG is observed filling the RGC cytoplasm, while Brn3a expression is nuclear (Fig. 1e). When the tracer is left for 7 days (standard procedure), there are usually no visible PMCs (Table 1). By 2 months, few PMCs are observed, both in the GCL and IPL. Note that at 2 months, the number of FG+RGCs decreases because FG is not a persistent label [39, 41, 42] but the number of Brn3a+RGCs remains unaltered (Fig. 1f–i, Table 1). In the right retinas, contralateral to the lesion, there is no RGC loss and the presence of PMCs is testimonial (Fig. 1i, j’, Table 1).

RGC death vs. RGC clearance

After ONC or ONT, traced RGCs disappear and PMCs appear (Fig. 2a–j). The morphology of MCs after the lesion changes from ramified to fusiform or ameboid. Fusiform or rod-like MCs are preferentially found in chains, along the RGC axons. Ameboid MCs are found more often engulfing a traced RGC which, normally, does not express Brn3a anymore (Figs. 2 and 3a).
Fig. 2

RGC clearance and PMC appearance in axotomized retinas. Magnifications from flat-mounted traced retinas analyzed at 2 (a, b), 5 (c, d), 9 (e, f), 14 days (g, h), or 2 months (i, j) after optic nerve crush (first column) or transection (second column) showing the course of FG+RGC disappearance and the appearance of PMCs (yellow arrows). kn Images from the central dorso-temporal area (drawing in k, top right) of a representative retina analyzed 14 days after ONT and immunodetected with Iba1 and Brn3a. PMCs are those MCs transcellularly labeled (FG + Iba + ). In these injured retinas, majority of FG Iba + MCs are probably activated, but have not yet engulfed a traced RGC

Fig. 3

Microglial cell morphologies, quantitative topography, and correlation analyses of PMC appearance, RGC clearance, and RGC death. a Microglial cells in control or axotomized retinas: magnifications from control or injured FG-traced retinas immunodetected for Iba1 and Brn3a taken from the red areas shown in the retinal drawing. Arrows, PMCs. Arrowheads, activated MCs that have not yet engulfed a traced RGC. Asterisk, MC engulfing a traced RGC that has lost its Brn3a expression. b Temporal course of RGC loss and PMC appearance. The yellow line is the number of SMCs in intact retinas. c Correlation analyses created from total mean numbers ± standard deviation. First row, PMCs vs. time; lineal fit. Second row, FG+RGCs vs. time; lineal fit. Third row, Brn3a+RGCs vs. time; lineal segmental fit. Fourth row, FG+RGCs vs. PMCs; lineal fit. R 2 is the correlation coefficient. m is the slope of the straight line. X 0 is the day when the first linear phase of RGC loss changes to a second, slower one. m 1 and m 2 are the slopes of the first and second linear phases, respectively. Fifty percent appearance, clearance, or loss is the time (days) when, according to the mathematical analysis, half of the PMCs have appeared, half of the RGCs have been cleared from the tissue, or half of the RGCs have died, respectively. Left column ONC, right column ONT. d Quantitative topography. Line graphs where the mean number or percent of cells (Y-axis) counted after ONC (left column) or ONT (right columns) are plotted against the length of the retina (X-axis) being 0 the optic nerve and 6 mm the periphery. First row, number of Brn3a+RGCs. Second row, Brn3a+RGCs as percent of intact retinas (blue line). Third row, number of MCs, which are surveying MCs for intact retinas and PMCs for injured ones. Fourth row, percent of PMCs, being 100% the number of SMCs in intact retinas (blue line)

As previously reported [2, 34], RGC loss after ONC is slower than after ONT, and this is observed with both identification methods (Table 2 and Fig. 3b, c). However, there are differences between the course of RGC death (Brn3a) and RGC clearance (FG).
Table 2

Injured retinas

  

Retinal nerve fiber layer/ganglion cell layer

Inner plexiform layer

Ganglion cell complex (GCL + IPL)

Brn3a+ RGCs

FG+ RGCs

PMCs

Non-PMCs

Total MCs

PMCs

Non-PMCs

Total MCs

ONC

2 days (n = 8)

75,987 ± 4210

80,459 ± 1552

11 ± 5

      

5 days (n = 8)

42,656* ± 5111

67,302* ± 5901

3116* ± 740

      

9 days (n = 8)

25,105* ± 5789

30,896* ± 1719

13,401* ± 2549

      

14 days (n = 12)

10,639* ± 3150

15,755* ± 3359

22,404* ± 1863

2801 ± 350

23,206 ± 1070

760* ± 132

4501 ± 546

5261± 404

28,467 ± 1555

2 months (n = 4)

5457 ± 1724

8580* ± 385

10,497* ± 289

2375 ± 408

12,871± 374

2343 ± 304

4694 ± 499

7038± 660

19,910± 948

ONT

2 days (n = 8)

67,466*† ± 5539

79,997 ± 1345

43 ± 8

      

5 days (n = 8)

31,938*† ± 4829

54,290*† ± 4136

5025* ± 1058

      

9 days (n = 8)

18,015* ± 4542

22,002*† ± 1336

19,842*† ± 2534

      

14 days (n = 12)

5515* ± 1101

8627*† ± 1433

22,092† ± 3514

2258 ± 412

24,351† ± 2193

941* ± 211

4760 ± 801

5702± 792

30,053 ± 2202

2 months (n = 4)

2708 ± 813

2983* ± 232

10,865* ± 584

3280 ± 685

14,145± 410

3971† ± 125

3756 ± 356

7728± 332

21,873± 415

Mean number ± standard deviation of Brn3a+RGCs, FG+RGCs, phagocytic microglial cells (PMCs), and non-phagocytic microglial cells (non-PMCs, surveying and/or activated microglial cells that are not transcellularly labeled) in the same retinas within each group and time point. Total MCs is the sum of PMCs and non-PMCs

MC microglial cell, FG fluorogold, RGCs retinal ganglion cells, ONT optic nerve transection, ONC optic nerve crush, RNFL/GCL retinal nerve fiber layer + ganglion cell layer, IPL/INL inner plexiform layer + inner limit inner nuclear layer, GCC ganglion cell complex (RFNL/GCL + IPL/INL)

*Significant difference compared to previous time point (2 days or IPL 14 days vs. intact or tracing control retinas, Table 1)

†Significant difference between ONC and ONT at the same time point. One-way ANOVA and Tukey’s post hoc test, p < 0.05. The number of analyzed retinas to quantify GCL cells is shown in the second left column. For the IPL analysis, four retinas per group/time point were used

In bold font is shown the total number ± SD of MCs (PMCs plus non-PMCs) in the different retinal layers

Within each lesion, RGC loss is detected earlier with Brn3a than with FG. Indeed, half of the RGCs have died 5.6 days after ONC or 4.2 days after ONT, while half of the RGC clearance occurs 3 days later for both lesions (at 7.2 or 8.4 days respectively). Furthermore, RGC death adjusts to a segmental lineal regression with two phases of loss, one quick that lasts up to 7 days for ONC (daily loss of 7326 RGCs, m 1) or to 5.8 days for ONT (m 1, 9762 RGCs/day) and a slower one thereafter with a comparable rate of loss for both lesions (m2 values). For its part, RGC clearance is linear and the daily disappearance rate is similar between lesions (there are no significant differences in the slopes between ONC and ONT p = 0.59), albeit delayed for 1 day (see above) and less pronounced after ONC (5249 RGCs/day) than after ONT (5795 RGCs/day).

PMC dynamics

PMC appearance highly correlates with FG clearance (Fig. 3c), but not as much with RGC death (Brn3a+RGCs vs. PMCs, regression coefficient 0.84, not shown). Incidentally, the FG+RGCs vs. PMCs correlation tells us that for each 3288 or 3044 cleared RGCs, there is an increase of 1000 PMCs, meaning that one PMC is able to engulf ~ 3 RGCs. This ratio can also be estimated from the slope of FG+RGCs vs. time by the slope of PMCs vs. time (i.e., 5249/1789 = 2.9).

Quantitative analyses of cell topography show that more RGCs die in the central retina (Fig. 3d, first graph). Proportionately, though, their death is synchronous along the retina because the percent of loss is similar at any given distance from the optic nerve (Fig. 3d, second graph). In agreement, PMCs appear across the GCL, increasing in number with increasing post-lesion intervals, following the topographic pattern of RGC loss (Fig. 3d, compare the third graph with the first one). However, proportionally, the central retina bears a higher percent of PMCs than the periphery (Fig. 3d, fourth graph). This can be explained because there are more PMCs where more RGCs are dying, and this is clearly observed when the data are graphed as neighbor maps (Fig. 4); while RGC loss is diffuse, the emergence of PMCs seems centripetal being their density higher in the retinal areas where RGCs are more abundant (RGC distribution in an intact retina, Fig. 1g).
Fig. 4

Topographic correlation of PMC appearance and RGC death. Neighbor maps showing the spatial distribution of PMCs (aj) and Brn3a+RGCs (a’j’) in the same retinas within each group and time point after optic nerve transection (ae’) or crush (fj’). Map description is in Fig. 1 legend

Microglial migration between layers

PMCs peak at 14 days (Table 2). At this time point, ~ 90% of MCs in the GCL are PMCs which, as abovementioned, are more abundant in the areas of higher RGC density and death (Fig. 5a, e). The remaining 10% are non-PMCs and are distributed fairly homogenously, except for a dense accumulation around the optic nerve and along the extreme periphery (Fig. 5a’, e’).
Fig. 5

Migration of microglial cells between the ganglion cell layer and the inner plexiform layer after axotomy. Neighbor maps showing the spatial distribution of PMCs, non-PMC (non-phagocytic), or total MCs (sum of both) in the ganglion cell complex at 14 days and 2 months post-ONC (ad”) or ONT (eh”). Each column is the same retina, where MCs in the GCL and in the IPL have been analyzed. Map description is in Fig. 1 legend

At its highest, the number of PMCs + non-PMCs in the GCL surpasses the number of SMCs found in intact retinas by ~ 10,000. In parallel, there is a uniform decrease of MCs in the IPL (around 50% of their initial population) that justifies half of the excess observed in the GCL, suggesting that there is microglial migration between these layers (Table 2, Fig. 5b–b”, f–f”). Indeed, PMCs are observed orthogonally placed in the IPL and INL from 9 days onwards (Fig. 6).
Fig. 6

PMCs appear first in the ganglion cell layer and afterwards in the inner plexiform layer. Cross sections from control and injured traced retinas immunodetected with Brn3a. a Control. bf Injured at increasing times after axotomy. PMCs are observed at 2 and 5 days in the GCL, and they become apparent in the IPL/INL from 9 days onwards. Yellow arrows point to PMCs in the ganglion cell layer and blue ones to PMCs in the plexiform and inner nuclear layers

Two months after the lesions, when RGC death has slowed down, the number of MCs in the GCL has decreased and is numerically (Table 2) and topographically (Fig. 5c–c”, g–g”) normal, albeit most of these MCs are still transcellularly labeled. For its part, the IPL has partially recovered by the addition of PMCs which, most probably, come from the GCL (Table 2, Fig. 5d–d”, h–h”). However, the IPL, and therefore the GC complex, are deficient on 3000–5000 MCs compared to that on intact retinas.

Discussion

We describe here for the first time the numerical, mathematical, and topographical relationship between RGCs and MCs in healthy and injured rat retinas. The strengths of this work lie firstly on the fact that RGCs are the only retinal neurons that die after optic nerve axotomy [2, 4345] and, secondly, on the analysis of whole populations in the same retinas, using markers of RGC viability and clearance in combination with the identification of phagocytic and non-phagocytic microglial cells. We have limited our study to the retinal layers where the RGC axons, somata, and processes are and focused the analysis on the phagocytic response rather than on microglial activation [4649].

Intact retinas

In agreement with previous reports, MCs are homogenously distributed in the GCL and IPL of healthy retinas [46, 49]. This topography reflects their surveying function, explained by the continuous mobility of MCs and their multidirectional projections used to maintain the distance between surrounding cells [50].

In traced but otherwise intact rat retinas, the number of PMCs depends on the time of tracing, as it has been shown in mice [21]. In these retinas, we did not observe a significant loss of Brn3a+RGCs (at least up to 2 months). Thus, the presence of PMCs can be explained by phagocytosis of the FG excreted by the traced RGCs, by pruning of RGC neurites, and/or by direct toxicity of the tracer on a few RGCs. Our study does not allow to discriminate among these reasons, but given the very low number of PMCs quantified in these control retinas, tracing itself does not influence PMC quantification after injury.

Contralateral uninjured retinas

In mice, after unilateral ON axotomy, there is a strong PMC reaction in the contralateral (uninjured) retina that is constant, scattered, and independent of the rate of RGC survival in the axotomized retina [21, 24]. In rats, a contralateral response involving activation of MCs, astrocytes, and Müller cells has been observed after axotomy [47, 5154], or ocular hypertension [55], but to our knowledge, this is the first report describing that in this species, there is not a PMC reaction. At present, we do not know why, but it is possible that the scarce retino-retinal projection is implicated because in adult rats, this projection is missing in some animals and, when present, is smaller than in mice [5658]. Thus, retino-retinal RGCs, which are directly affected by the axotomy, could transmit a danger signal that would spread along the retina, recruiting and activating MCs. These signals would not be sufficient to elicit a PMC response in those rats with very few retino-retinal RGCs, and inexistent in those animals without them. In addition, these signals might combine with a systemic inflammatory response that would account for the inflammatory reaction observed in both species.

Microglial morphology

The role of MCs in neurodegenerative diseases is controversial, but it is clear that they are not simple bystanders [27]. For one part, MCs restore tissue homeostasis, keeping the neuronal interactions as healthy as possible [9, 10], and their suppression improves axonal regeneration and RGC survival after axotomy [59]. On the other hand, MC over-activation may be damaging [31], as they act as mediators of the inflammatory response observed in several retinal degenerative diseases (reviewed in [60]), although in this respect there is some debate [61].

Upon neuronal death, MCs change their morphology from a surveying ramified shape to an ameboid-like one, M1 phenotype, which is considered harmful [28, 6265]. Here, we show that ameboid PMCs are often found engulfing RGC somas. We also found phagocytic rod-shaped MCs, especially along the intraretinal axons, in agreement with other works describing that rod-shaped MCs are induced by the interruption of axonal transport after insults such as axotomy or ocular hypertension [46, 66], but also during aging [67]. Rod-shaped MCs bear the M2 phenotype, and although their function is unknown, it is hypothesized that they protect the degenerating neurons [29, 67, 68]. In apparent contradiction with that hypothesis, we show here that rod-shaped MCs are or have been involved in the phagocytic response. In other words, either they engulf FG in their rod-shape state, or they could change from an ameboid phagocytic state to a protective rod-shape during the course of RGC degeneration. Because FG is accumulated in the phagolysosomes of MCs for a long time after cleansing the tissue, at least 2 months as shown here, we cannot rule out either possibility.

RGC death and clearance

One of the most interesting results of this work is the 3 days delay between RGC death and RGC clearance that was observed after both lesions. This means that independently of the course of RGC loss (slower after ONC than after ONT), 3 days are needed for the MCs to become phagocytic. Therefore, to assess RGC death, tracing is not the best approach, particularly when manipulating MCs as neuroprotective tool, because MC inhibition may further delay the removal of dead RGCs from the tissue.

PMC migration

At 14 days, the number of PMCs in the GCL exceeds the population of SMCs in intact retinas by > 10,000. There are several theories to explain this increase: (I) microglial proliferation [6971], (II) extravasation of monocytes [72], and (III) migration from other retinal layers [59]. With our data, we cannot rule out (I) or (II). We found at 14 days, non-PMCs spread along the GCL, except around the optic nerve and the retinal periphery where they accumulated. They may reflect either local division, or retinal infiltration of monocytes from the ciliary bodies [73], and the peripapillary region. It is worth noting that these non-PMCs may or may not be activated, and although they have not engulfed RGC somas, they may have phagocytosed RGC axons, which do not accumulate FG. However, we do demonstrate that there is MC migration between the IPL and the GCL that would account for half of the MC surplus. Interestingly, 2 months after either lesion, the number of MCs in the GCL decreases, increasing in the IPL with cells from the GCL as the returning ones are PMCs. Finally, while the number of MCs in the GCL is back to normal, the IPL is short of ~ 4000 MCs. Have the missing MCs died? Or have they left the retina? We think that the second possibility is more plausible, because MC death would probably cause a second wave of MC activation and phagocytosis.

Topography

Our state-of-the-art topographical analyses show that more PMCs accumulate in the retinal regions where there is, proportionally, more RGC death. It is important to have in mind that RGC death is diffuse along the retina, meaning that RGCs die synchronously, but more of them die where there are more. Thus, there must be signals from the degenerating neurons and sensors in the MCs that inform of the amount of cell bodies to be removed, and upon them, more or less MCs migrate to the injured zone, having into account that one MC is able to engulf three RGC somatas. All in all, these results indicate that phagocytosis is activated by the death of RGCs rather than by the inflicted axonal damage.

Finally, our present data together with a previous work in mice [21] suggest that after optic nerve axotomy, MCs perform a cleansing role, but there is no indication of them being involved in the death of RGCs, at least during the quick phase of loss. In fact, Hilla et al. [74] have recently demonstrated, using an in vivo approach to deplete retinal MCs, that these cells do not play an active role on the death of RGCs after optic nerve axotomy.

Conclusion

In conclusion, after axotomy, RGC death precedes RGC clearance and there is an inverse correlation between RGC loss and PMC appearance, both numerically and topographically. Finally, to cope with the massive axotomy-induced RGC loss, MCs travel from the IPL to the GCL. The system appears restored at 2 months, when the GCL presents a normal number of MCs and the IPL has remodeled to its new status.

Abbreviations

ARVO: 

Association for Research in Vision and Ophthalmology

Brn3a: 

Brain-specific homeobox/POU domain protein 3a

DAPI: 

4′,6-Diamidino-2-phenylindole

dRGC(s): 

Displaced retinal ganglion cells

FG: 

Fluorogold

GCL: 

Ganglion cell layer

Iba1: 

Ionized calcium-binding adapter molecule 1

INL: 

Inner nuclear layer

IPL: 

Inner plexiform layer

MCs: 

Microglial cells

n

Sample size

Non-PMC(s): 

Non-phagocytic microglial cells

OCT: 

Optimal cutting temperature

ON: 

Optic nerve

ONC: 

Optic nerve crush

ONL: 

Outer nuclear layer

ONT: 

Optic nerve transection

OPL: 

Outer plexiform layer

PMC(s): 

Phagocytic microglial cells

RGC(s): 

Retinal ganglion cells

RNFL: 

Retinal nerve fiber layer

SCi: 

Superior colliculi

SMC(s): 

Surveying microglial cells

vs.: 

Versus

Declarations

Acknowledgements

The authors thank Isabel Cánovas-Martínez and Leticia Nieto-Lopez for their technician support. We are thankful to the veterinarians and technicians at the animal housing facilities of the University of Murcia, especially Yolanda Martínez-Verdú and Francisco J. Zapata-Nicolás for their help and support during this long-term experiment.

Funding

This study was funded by Fundación Séneca, Agencia de Ciencia y Tecnología Región de Murcia (19881/GERM/15), and the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional “Una Manera de Hacer Europa” (SAF2015-67643-P, PI16/00031).

Availability of data and materials

Please contact author for data requests.

Authors’ contributions

FMN-N and MA-B conceived and designed the experiments. FMN-N, MS-N, and PS-C performed the experiments. FMN-N did the data collection. MJ-L made the macro-design. FMN-N, MJ-L, MS-N, and MA-B carried out the data analysis. FMN-N and MA-B wrote the manuscript. MA-B and MV-S funded the project. All authors reviewed and approved the final version.

Ethics approval

All animals were treated in compliance with the European Union guidelines for Animal Care and Use for Scientific Purpose (Directive 2010/63/EU) and the guidelines from the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research. All procedures were approved by the Ethical and Animal Studies Committee of the University of Murcia, Spain (REGA 300305440012).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Grupo de Oftalmología Experimental, Instituto Murciano de Investigación Biosanitaria-Virgen de la Arrixaca
(2)
Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia
(3)
Present address: Retinal Neurophysiology Section, National Eye Institute, National Institutes of Health

References

  1. Vidal-Sanz M, Galindo-Romero C, Valiente-Soriano FJ, et al. Shared and differential retinal responses against optic nerve injury and ocular hypertension. Front Neurosci. 2017;11:235.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Nadal-Nicolás FM, Sobrado-Calvo P, Jiménez-López M, et al. Long-term effect of optic nerve axotomy on the retinal ganglion cell layer. Invest Ophthalmol Vis Sci. 2015;56:6095–112.View ArticlePubMedGoogle Scholar
  3. Villegas-Pérez MP, Vidal-Sanz M, Rasminsky M, et al. Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol. 1993;24:23–36.View ArticlePubMedGoogle Scholar
  4. Sánchez-Migallón MC, Valiente-Soriano FJ, Nadal-Nicolás FM, et al. Apoptotic retinal ganglion cell death after optic nerve transection or crush in mice: delayed RGC loss with BDNF or a caspase 3 inhibitor. Invest Ophthalmol Vis Sci. 2016;57:81–93.View ArticlePubMedGoogle Scholar
  5. Berkelaar M, Clarke DB, Wang YC, et al. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 1994;14:4368–74.PubMedGoogle Scholar
  6. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–57.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Schwartz LM, Smith SW, Jones ME, et al. Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci U S A. 1993;90:980–4.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Nadal-Nicolás FM, Salinas-Navarro M, Jiménez-López M, et al. Displaced retinal ganglion cells in albino and pigmented rats. Front Neuroanat. 2014;6;8:99.Google Scholar
  9. Wang X, Zhao L, Zhang J, et al. Requirement for microglia for the maintenance of synaptic function and integrity in the mature retina. J Neurosci. 2016;36:2827–42.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Wong WT. Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation. Front Cell Neurosci. 2013;13(7):22.Google Scholar
  11. Di Pierdomenico J, García-Ayuso D, Jiménez-López M, et al. Different ipsi- and contralateral glial responses to anti-VEGF and triamcinolone intravitreal injections in rats. Invest Ophthalmol Vis Sci. 2016;57:3533–44.View ArticlePubMedGoogle Scholar
  12. Mac Nair CE, Schlamp CL, Montgomery AD, et al. Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways. J Neuroinflammation. 2016;13:93.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Paques M, Simonutti M, Augustin S, et al. In vivo observation of the locomotion of microglial cells in the retina. Glia. 2010;58:1663–8.View ArticlePubMedGoogle Scholar
  14. Chen L, Yang P, Kijlstra A. Distribution, markers, and functions of retinal microglia. Ocul Immunol Inflamm. 2002;10:27–39.View ArticlePubMedGoogle Scholar
  15. Wolf SA, Boddeke HW, Kettenmann H. Microglia in physiology and disease. Annu Rev Physiol. 2017;79:619–43.View ArticlePubMedGoogle Scholar
  16. Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441–68.View ArticlePubMedGoogle Scholar
  17. Diaz-Aparicio I, Beccari S, Abiega O, Sierra A. Clearing the corpses: regulatory mechanisms, novel tools, and therapeutic potential of harnessing microglial phagocytosis in the diseased brain. Neural Regen Res. 2016;11:1533–9.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Zabel MK, Zhao L, Zhang Y, et al. Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1-CX3CR1 signaling in a mouse model of retinitis pigmentosa. Glia. 2016;64:1479–91.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Thanos S. The relationship of microglial cells to dying neurons during natural neuronal cell death and axotomy-induced degeneration of the rat retina. Eur J Neurosci. 1991;3:1189–207.View ArticlePubMedGoogle Scholar
  20. Thanos S, Pavlidis C, Mey J, et al. Specific transcellular staining of microglia in the adult rat after traumatic degeneration of carbocyanine-filled retinal ganglion cells. Exp Eye Res. 1992;55:101–17.View ArticlePubMedGoogle Scholar
  21. Galindo-Romero C, Valiente-Soriano FJ, Jiménez-López M, et al. Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia. Invest Ophthalmol Vis Sci. 2013;54:974–85.View ArticlePubMedGoogle Scholar
  22. Nadal-Nicolas FM, Jimenez-Lopez M, Salinas-Navarro M, et al. Temporal response of the phagocytic microglia in the axotomized rat retina: optic nerve crush vs. transection. Acta Ophthalmol. 2014; 10.1111/j.1755-3768.2014.S007.x.
  23. Vidal-Sanz M, Nadal-Nicolas FM, Sobrado-Calvo P, et al. Quantitative and topographical microglial cell changes in the ganglion cell layer and inner plexiform layer after optic nerve axotomy. Invest Ophthalmol Vis Sci. 2016;57:2226.Google Scholar
  24. Nadal-Nicolás FM, Galindo-Romero C, Valiente-Soriano FJ, et al. Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury. Sci Rep. 2016;6:38499.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Salinas-Navarro M, Mayor-Torroglosa S, Jiménez-López M, et al. A computerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats. Vis Res. 2009;49:115–26.View ArticlePubMedGoogle Scholar
  26. Nadal-Nicolás FM, Salinas-Navarro M, Vidal-Sanz M, et al. Two methods to trace retinal ganglion cells with fluorogold: from the intact optic nerve or by stereotactic injection into the optic tract. Exp Eye Res. 2015;131:12–9.View ArticlePubMedGoogle Scholar
  27. Karlstetter M, Scholz R, Rutar M, et al. Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res. 2015;45:30–57.View ArticlePubMedGoogle Scholar
  28. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007;81:1345–51.View ArticlePubMedGoogle Scholar
  29. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol. 1999;57:563–81.View ArticlePubMedGoogle Scholar
  30. Ellis-Behnke RG, Jonas RA, Jonas JB. The microglial system in the eye and brain in response to stimuli in vivo. J Glaucoma. 2013;22(Suppl 5):S32–5.View ArticlePubMedGoogle Scholar
  31. Marín-Teva JL, Cuadros MA, Martín-Oliva D, et al. Microglia and neuronal cell death. Neuron Glia Biol. 2011;7:25–40.View ArticlePubMedGoogle Scholar
  32. Ramirez AI, de Hoz R, Salobrar-Garcia E, et al. The role of microglia in retinal neurodegeneration: Alzheimer’s disease, Parkinson, and glaucoma. Front Aging Neurosci. 2017; 10.3389/fnagi.2017.00214.
  33. Baptista FI, Aveleira CA, Castilho ÁF, et al. Elevated glucose and interleukin-1β differentially affect retinal microglial cell proliferation. Mediat Inflamm. 2017;4316316:2017.Google Scholar
  34. Nadal-Nicolás FM, Jiménez-López M, Sobrado-Calvo P, et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci. 2009;50:3860–8.View ArticlePubMedGoogle Scholar
  35. Salinas-Navarro M, Jiménez-López M, Valiente-Soriano FJ, et al. Retinal ganglion cell population in adult albino and pigmented mice: a computerized analysis of the entire population and its spatial distribution. Vis Res. 2009;49:637–47.View ArticlePubMedGoogle Scholar
  36. Parrilla-Reverter G, Agudo M, Nadal-Nicolás F, et al. Time-course of the retinal nerve fibre layer degeneration after complete intra-orbital optic nerve transection or crush: a comparative study. Vis Res. 2009;49:2808–25.View ArticlePubMedGoogle Scholar
  37. Nadal-Nicolás FM, Jiménez-López M, Salinas-Navarro M, et al. Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PLoS One. 2012;7(11):e49830.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Nadal-Nicolás FM, Rodriguez-Villagra E, Bravo-Osuna I, et al. Ketorolac administration attenuates retinal ganglion cell death after axonal injury. Invest Ophthalmol Vis Sci. 2016;57:1183–92.View ArticlePubMedGoogle Scholar
  39. Nadal-Nicolás FM, Madeira MH, Salinas-Navarro M, et al. Transient downregulation of melanopsin expression after retrograde tracing or optic nerve injury in adult rats. Invest Ophthalmol Vis Sci. 2015;56:4309–23.View ArticlePubMedGoogle Scholar
  40. Nadal-Nicolas FM, Vidal-Sanz M, Agudo-Barriuso M. The aging rat retina: from function to anatomy. Neurobiol Aging. 2017; 10.1016/j.neurobiolaging.2017.09.021.
  41. Gómez-Ramírez AM, Villegas-Pérez MP, Miralles de Imperial J, et al. Effects of intramuscular injection of botulinum toxin and doxorubicin on the survival of abducens motoneurons. Invest Ophthalmol Vis Sci. 1999;40:414–24.PubMedGoogle Scholar
  42. Sellés-Navarro I, Villegas-Pérez MP, Salvador-Silva M, et al. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:2002–14.PubMedGoogle Scholar
  43. Ortín-Martínez A, Salinas-Navarro M, Nadal-Nicolás FM, et al. Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors. Exp Eye Res. 2015;132:17–33.View ArticlePubMedGoogle Scholar
  44. Janssen KT, Mac Nair CE, Dietz JA, et al. Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis. Invest Ophthalmol Vis Sci. 2013;54:1805–15.View ArticlePubMedPubMed CentralGoogle Scholar
  45. He T, Mortensen X, Wang P, et al. The effects of immune protein CD3ζ development and degeneration of retinal neurons after optic nerve injury. PLoS One. 2017;12(4):e0175522.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Sobrado-Calvo P, Vidal-Sanz M, Villegas-Pérez MP. Rat retinal microglial cells under normal conditions, after optic nerve section, and after optic nerve section and intravitreal injection of trophic factors or macrophage inhibitory factor. J Comp Neurol. 2007;501(6):866–78.View ArticlePubMedGoogle Scholar
  47. Cen LP, Han M, Zhou L, et al. Bilateral retinal microglial response to unilateral optic nerve transection in rats. Neuroscience. 2015;311:56–66.View ArticlePubMedGoogle Scholar
  48. Garcia-Valenzuela E, Sharma SC, Piña AL. Multilayered retinal microglial response to optic nerve transection in rats. Mol Vis. 2005;11:225–31.PubMedGoogle Scholar
  49. Santos AM, Calvente R, Tassi M, et al. Embryonic and postnatal development of microglial cells in the mouse retina. J Comp Neurol. 2008;506:224–39.View ArticlePubMedGoogle Scholar
  50. Lee JE, Liang KJ, Fariss RN, et al. Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy. Invest Ophthalmol Vis Sci. 2008;49:4169–76.View ArticlePubMedPubMed CentralGoogle Scholar
  51. Bodeutsch N, Siebert H, Dermon C, et al. Unilateral injury to the adult rat optic nerve causes multiple cellular responses in the contralateral site. J Neurobiol. 1999;38:116–28.View ArticlePubMedGoogle Scholar
  52. Ito D, Imai Y, Ohsawa K, et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998;57:1–9.View ArticlePubMedGoogle Scholar
  53. Panagis L, Thanos S, Fischer D, et al. Unilateral optic nerve crush induces bilateral retinal glial cell proliferation. Eur J Neurosci. 2005;21:2305–9.View ArticlePubMedGoogle Scholar
  54. Liu S, Li ZW, Weinreb RN, et al. Tracking retinal microgliosis in models of retinal ganglion cell damage. Invest Ophthalmol Vis Sci. 2012;53:6254–62.View ArticlePubMedGoogle Scholar
  55. Ramírez AI, Salazar JJ, de Hoz R, et al. Quantification of the effect of different levels of IOP in the astroglia of the rat retina ipsilateral and contralateral to experimental glaucoma. Invest Ophthalmol Vis Sci. 2010;51:5690–6.View ArticlePubMedGoogle Scholar
  56. Müller M, Holländer H. A small population of retinal ganglion cells projecting to the retina of the other eye. An experimental study in the rat and the rabbit. Exp Brain Res. 1988;71:611–7.View ArticlePubMedGoogle Scholar
  57. Avellaneda-Chevrier VK, Wang X, Hooper ML, et al. The retino-retinal projection: tracing retinal ganglion cells projecting to the contralateral retina. Neurosci Lett. 2015;591:105–9.View ArticlePubMedGoogle Scholar
  58. Nadal-Nicolás FM, Valiente-Soriano FJ, Salinas-Navarro M, et al. Retino-retinal projection in juvenile and young adult rats and mice. Exp Eye Res. 2015;134:47–52.View ArticlePubMedGoogle Scholar
  59. Thanos S, Richter W. The migratory potential of vitally labelled microglial cells within the retina of rats with hereditary photoreceptor dystrophy. Int J Dev Neurosci. 1993;11:671–80.View ArticlePubMedGoogle Scholar
  60. Madeira MH, Boia R, Santos PF, et al. Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediat Inflamm. 2015;673090:2015.Google Scholar
  61. Chen Z, Jalabi W, Shpargel KB, et al. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci. 2012;32:11706–15.View ArticlePubMedPubMed CentralGoogle Scholar
  62. Karlstetter M, Ebert S, Langmann T. Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology. 2010;215:685–91.View ArticlePubMedGoogle Scholar
  63. Madeira MH, Elvas F, Boia R, et al. Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure. J Neuroinflammation. 2015;12:115.View ArticlePubMedPubMed CentralGoogle Scholar
  64. Davis BM, Salinas-Navarro M, Cordeiro MF, et al. Characterizing microglia activation: a spatial statistics approach to maximize information extraction. Sci Rep. 2017;7:1576.View ArticlePubMedPubMed CentralGoogle Scholar
  65. Jonas RA, Yuan TF, Liang YX, et al. The spider effect: morphological and orienting classification of microglia in response to stimuli in vivo. PLoS One. 2012;7(2):e30763.View ArticlePubMedPubMed CentralGoogle Scholar
  66. de Hoz R, Gallego BI, Ramírez AI, et al. Rod-like microglia are restricted to eyes with laser-induced ocular hypertension but absent from the microglial changes in the contralateral untreated eye. PLoS One. 2013;8(12):e83733.View ArticlePubMedPubMed CentralGoogle Scholar
  67. Bachstetter AD, Ighodaro ET, Hassoun Y, et al. Rod-shaped microglia morphology is associated with aging in 2 human autopsy series. Neurobiol Aging. 2017;52:98–105.View ArticlePubMedGoogle Scholar
  68. Trapp BD, Wujek JR, Criste GA, et al. Evidence for synaptic stripping by cortical microglia. Glia. 2007;55:360–8.View ArticlePubMedGoogle Scholar
  69. Garcia-Valenzuela E, Sharma SC. Laminar restriction of retinal macrophagic response to optic nerve axotomy in the rat. J Neurobiol. 1999;40:55–66.View ArticlePubMedGoogle Scholar
  70. Wohl SG, Schmeer CW, Witte OW, et al. Proliferative response of microglia and macrophages in the adult mouse eye after optic nerve lesion. Invest Ophthalmol Vis Sci. 2010;51:2686–96.View ArticlePubMedGoogle Scholar
  71. Wohl SG, Schmeer CW, Friese T, et al. In situ dividing and phagocytosing retinal microglia express nestin, vimentin, and NG2 in vivo. PLoS One. 2011;6(8):e22408.View ArticlePubMedPubMed CentralGoogle Scholar
  72. Trost A, Motloch K, Bruckner D, et al. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension. Exp Eye Res. 2015;136:59–71.View ArticlePubMedGoogle Scholar
  73. Zhang Y, Zhao L, Wang X, et al. Microglia homeostasis in the adult mouse retina: restoration of microglial distribution, morphology, and function following acute depletion. Invest Ophthalmol Vis Sci. 2017;58:806.Google Scholar
  74. Hilla AM, Diekmann H, Fischer D. Microglia are irrelevant for neuronal degeneration and axon regeneration after acute injury. J Neurosci. 2017;37:6113–24.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement